Product Detail
Product NameGARS Rabbit mAb
Clone No.SC0651
Host SpeciesRecombinant Rabbit
Clonality Monoclonal
PurificationProA affinity purified
ApplicationsWB, IHC
Species ReactivityHu, Ms, Rt
Immunogen Descrecombinant protein
ConjugateUnconjugated
Other NamesAP 4 A synthetase antibody Charcot Marie Tooth neuropathy 2D antibody Charcot Marie Tooth neuropathy neuronal type D antibody CMT2D antibody Diadenosine tetraphosphate synthetase antibody DSMAV antibody EC 6.1.1.14 antibody Glycine tRNA ligase antibody Glycyl tRNA synthetase antibody GlyRS antibody HMN5 antibody SMAD1 antibody
Accession NoSwiss-Prot#:P41250
Uniprot
P41250
Gene ID
2617;
Calculated MW75 kDa
Formulation1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
StorageStore at -20˚C
Application Details
WB: 1:1,000-1:2,000
IHC: 1:50-1:200
Western blot analysis of GARS on Raji cells lysates using anti-GARS antibody at 1/1,000 dilution.
Immunohistochemical analysis of paraffin-embedded mouse colon tissue using anti-GARS antibody. Counter stained with hematoxylin.
Immunohistochemical analysis of paraffin-embedded mouse heart tissue using anti-GARS antibody. Counter stained with hematoxylin.
The fidelity of protein synthesis requires efficient discrimination of amino acid substrates by aminoacyl-tRNA synthetases. Proteins belonging to this family function to catalyze the aminoacylation of tRNAs by their corresponding amino acids, thus linking amino acids with tRNA-contained nucleotide triplets. GlyRS (Glycyl-tRNA synthetase), also known as Glycine-tRNA ligase, is a 739 amino acid class II synthetase that is widely expressed, including in the brain and spinal cord. Defects in the gene encoding GlyRS is the cause of Charcot-Marie-Tooth disease type 2D (CMT2D), which is an autosomal dominant inherited disease characterized by severe weakness, atrophy and absence of deep tendon reflexes in the upper extremities. Defects in the GlyRS gene is also the cause of distal hereditary muscular neuropathy type V (HMN5), a disease similar to CMT2D, though the distal sensory involvement is less severe in HMN5 patients.
If you have published an article using product 48983, please notify us so that we can cite your literature.
Yes
